Inhaled Nitric Oxide Market
According to Intent Market Research, the Inhaled Nitric Oxide Market is expected to grow from USD 0.7 Billion in 2024-e at a CAGR of 7.4% to touch USD 1.1 Billion by 2030. The Inhaled Nitric Oxide Market is dominated by key players such as, Mallinckrodt Pharmaceuticals, Linde Group, Air Products and Chemicals, Inc., Praxair Technology, Merck & Co., Inc., and Siemens Healthineers.